FY20 consolidated facilities task order c- refurbishment and infrastructure projects focused on facility improvements within the NCI at frederick campus.
Ended Awarded Last action
- Contract number
- 75N91020F00012
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,671,952
Award facts
- Contract value 100% obligated
- $10,671,952.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $100,132 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $285,808 | |
| Other Administrative Action | $130,368 | |
| Original award | $10,155,644 |
Show all 12
About this award
This is a $10,671,952.00 Cost Plus Fixed Fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for refurbishment and infrastructure projects focused on facility improvements within the NCI at Frederick campus, located in Fort Detrick, Maryland. This contract is not set aside for any specific business category. Leidos Biomedical Research is an experienced provider of a range of research, development, and production services to federal agencies, particularly the NIH, in support of biomedical research programs. This includes work as both a prime contractor and subcontractor under larger NIH contract vehicles supporting areas such as cancer, HIV/AIDS, and COVID-19 research.
Quick answers
Who was awarded contract 75N91020F00012?
75N91020F00012 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on July 21, 2020.
How much is contract 75N91020F00012 worth?
The government has obligated $10,671,952 on 75N91020F00012.
Is contract 75N91020F00012 an order under another contract?
Yes. 75N91020F00012 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00012 competed?
The extent of competition for 75N91020F00012 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award